ALMIRALL, S.A. «...678910...» Page 10 out of 18 21/02/2022 07:00 ALMIRALL, S.A. Annual financial reports and audit reports La sociedad remite el Informe Financiero Anual del ejercicio 2021 Register number: 14138 21/02/2022 06:18 ALMIRALL, S.A. Announcement of general shareholders’ meeting Convocatoria de la Junta General Ordinaria de Accionistas de la Sociedad Register number: 14137 21/02/2022 06:15 ALMIRALL, S.A. Annual report on directors´ remunerations La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del Ejercicio 2021 Register number: 14136 21/02/2022 06:13 ALMIRALL, S.A. Annual corporate governance report La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2021 Register number: 14135 21/02/2022 06:05 ALMIRALL, S.A. Half-yearly financial reports and audit reports/limited audit review La sociedad remite información financiera del segundo semestre de 2021 Register number: 14134 21/02/2022 06:03 ALMIRALL, S.A. Other relevant information A webcast with analysts and institutional investors FY 2021 Register number: 14133 11/01/2022 10:12 ALMIRALL, S.A. Other relevant information Presentation: 40th Annual J.P. Morgan Healthcare Conference 2022 Register number: 13560 05/01/2022 07:58 ALMIRALL, S.A. Other relevant information Transfer of global rights for Eklira and Duaklir to Covis Pharma completed Register number: 13482 Related to communication no. 12510 dated 01/11/2021 (08:01) 04/01/2022 17:48 ALMIRALL, S.A. Liquidity and counterparty agreements Operaciones del contrato de liquidez durante el cuarto trimestre de 2021 Register number: 13480 21/12/2021 06:01 ALMIRALL, S.A. On business and financial situation Almirall: Lebrikizumab demonstrated significant skin improvement and itch relief when combined with topical corticosteroids in people with atopic dermatitis in third Phase 3 study Register number: 13291 Page 10 out of 18 «...678910...»
